UNVERIFIEDSingle SourceSTAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeuticsStat News|6/3/2026
UNVERIFIEDSingle SourceSTAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trialStat News|6/2/2026
UNVERIFIEDSingle SourceSTAT+: Radiopharmaceutical shows promise in post-Pluvicto settingStat News|6/2/2026
UNVERIFIEDSingle SourceSTAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concernsStat News|6/1/2026
UNVERIFIEDSingle SourceSTAT+: At ASCO, talk of barriers to cancer care, new treatments, and other big takeawaysStat News|6/1/2026
UNVERIFIEDSingle SourceSTAT+: Servier to buy Edgewise Therapeutics’ muscular dystrophy drugStat News|6/1/2026
UNVERIFIEDSingle SourceSTAT+: A standing ovation for RevMed, and caution for AkesoStat News|5/31/2026
UNVERIFIEDSingle SourceUltra-low doses could bring costly cancer treatments to more patients in poorer countriesStat News|5/31/2026
UNVERIFIEDSingle SourceWhat happens in Vega$: steroids, swimmers, and a billion-dollar hustleTechCrunch|5/31/2026
UNVERIFIEDSingle SourceSTAT+: For prostate cancer patients set on surgery, new hormone regimen may improve outcomes, study findsStat News|5/31/2026
UNVERIFIEDSingle SourceSTAT+: Akeso and Summit’s ivonescimab extends survival in squamous cell lung cancerStat News|5/31/2026
UNVERIFIEDSingle SourceSTAT+: Practice-changing results reported for Revolution Medicines pancreatic cancer drugStat News|5/31/2026
UNVERIFIEDSingle SourceSTAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDAStat News|5/30/2026
UNVERIFIEDSingle SourceSTAT+: China competition, ‘destruction’ at FDA gives agency chance to restructure, Rick Pazdur saysStat News|5/30/2026
UNVERIFIEDSingle SourceSTAT+: Revolution Medicines starts shipping experimental pancreatic cancer drugStat News|5/30/2026
UNVERIFIEDSingle SourceI went to the so-called ‘steroid Olympics,’ to understand why Silicon Valley is obsessed with peptidesTechCrunch|5/30/2026
UNVERIFIEDSingle SourceSTAT+: At ASCO, positive data for Bristol in multiple myeloma and Pfizer in lung cancerStat News|5/29/2026
UNVERIFIEDSingle SourceSTAT+: Biotech veteran Jeremy Levin on why the industry’s future is secure, but American leadership is at riskStat News|5/28/2026
UNVERIFIEDSingle SourceSTAT+: An ASCO preview: What to watch for at cancer research’s big meetingStat News|5/28/2026